Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
International Cancer Conference Journal|June 1, 2019
Thymic cancer mimicking a metastasis of testicular seminomaTomohiro Fukui, Naoki Terada, Masashi Takeda, et al.
Micromachines|October 9, 2019
Viscosity Estimation of a Suspension with Rigid Spheres in Circular Microchannels Using Particle Tracking VelocimetryMisa Kawaguchi, Tomohiro Fukui, Kenichi Funamoto, et al.
Japanese Journal of Clinical Oncology|March 11, 2016
Predictive value of radiological response rate for pathological response to neoadjuvant chemotherapy and post-cystectomy survival of bladder urothelial cancerTomohiro Fukui, Yoshiyuki Matsui, Shigeaki Umeoka, et al.
Hinyokika Kiyo. Acta Urologica Japonica|March 8, 2017
[Low-Dose Estramustine Phosphate Monotherapy in Castration-Resistant Prostate Cancer Patients]Tomohiro Fukui, Kenji Nakamura, Toru Sakatani, et al.
Hinyokika Kiyo. Acta Urologica Japonica|March 3, 2016
[A Case of Bisphosphonate-Related Osteonecrosis of the Jaw with Difficulty in Treatment]Kenji Nakamura, Tetsuya Fukumoto, Tomohiro Fukui, et al.
Investigative Ophthalmology & Visual Science|January 14, 2026
Protective Effects of Estradiol on Disease Progression in a Murine Model of Fuchs Endothelial Corneal DystrophyItsuki Oka, Sohya Fujimoto, Tomohiro Fukui, et al.
Hinyokika Kiyo. Acta Urologica Japonica|November 14, 2014
[A case of late perirenal fat recurrence after partial nephrectomy for T1A renal cell carcinoma]Tomohiro Fukui, Toshinari Yamasaki, Kei Mizuno, et al.
Frontiers in Oncology|September 19, 2025
Case Report: Genomic insights into prostate adenocarcinoma transdifferentiation to carcinosarcoma due to lineage plasticityTomohiro Fukui, Arinobu Fukunaga, Yuki Teramoto, et al.
Frontiers in Oncology|April 17, 2023
Extracellular vesicles secreted from bone metastatic renal cell carcinoma promote angiogenesis and endothelial gap formation in bone marrow in a time-dependent manner in a preclinical mouse modelMasashi Takeda, Hiromasa Sakamoto, Noboru Shibasaki, et al.
Molecular Cancer Therapeutics|May 14, 2026
Dual inhibition of PARP and ATR induces synthetic lethal vulnerability in prostate cancer with CDK12 deficiencyYuki Kamiyama, Takuro Sunada, Yutaka Kanoh, et al.
Pageof 4